Webcigna's $67 billion acquisition of express scripts received approval from new jersey regulators tuesday, meaning the deal has won all the necessary regulatory.
Webon tuesday, sanofi and regeneron announced that the original $14,000 annual cost of the cholesterol drug alirocumab (praluent) would drop up to 75% for.
Federal trade commission on tuesday over the regulator's recent drug pricing.
Webcigna ceo david cordani talks to thestreet on the progress of getting company's big deal for express scripts passed by regulators.
Webexpress scripts and its fellow pbm behemoth cvs health recently published new exclusions on their formularies, following up on their vows to pit.